AI
Monday, January 26, 2009 10:10:43 PM
EVSC .001x.0015 Stem Cell Recruitment...
Endovasc Ltd, Inc. - a biotechnology firm with two cardiovascular drugs approved for FDA Phase III trials, announced today that it has signed a Letter of Intent with XM International d/b/a Basic Research, Inc. to start a stem cell recruitment study using Angiogenix(TM) for accelerating muscle tissue rebuilding after long term disability.
Before Metabolic Research, Inc. (the company that makes Stemulite), Dr. Summers founded a company called Endovasc.
http://www.blog.stephenholtfitness.com/562/comments-on-stemulite-forum-reviews/
Endovasc Ltd, Inc. - a biotechnology firm with two cardiovascular drugs approved for FDA Phase III trials, announced today that it has signed a Letter of Intent with XM International d/b/a Basic Research, Inc. to start a stem cell recruitment study using Angiogenix(TM) for accelerating muscle tissue rebuilding after long term disability.
Before Metabolic Research, Inc. (the company that makes Stemulite), Dr. Summers founded a company called Endovasc.
http://www.blog.stephenholtfitness.com/562/comments-on-stemulite-forum-reviews/
___________________________________________________
"The only thing necessary for the triumph of evil is for good [people] to do nothing." --Edmund Burke
Discover What Traders Are Watching
Explore small cap ideas before they hit the headlines.
